NEUTROGENA SCALP THERAPY ANTI-DANDRUFF DAILY CONTROL- salicylic acid shampoo 
Johnson & Johnson Consumer Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

NEUTROGENA ® Scalp Therapy TM Anti-Dandruff Daily Control Shampoo

Drug Facts

Active ingredient

Salicylic Acid (1.8%)

Purposes

Anti-dandruff, Anti-seborrheic dermatitis, Anti-psoriasis

Use

Controls the symptoms of dandruff, seborrheic dermatitis and psoriasis.

Warnings

  • Ask a doctor before use if you have a condition that covers a large area of the body.

  • When using this product avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.

  • Stop use and ask a doctor if condition worsens or does not improve after regular use of this product as directed.

  • Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

Store at room temperature.

Inactive ingredients

Water, Sodium C14-16 Olefin Sulfonate, Cocamidopropyl Betaine, Sodium Chloride, Polyquaternium-22, Sodium Citrate, Hexylene Glycol, Sodium Lauroyl Sarcosinate, Fragrance, Linoleamidopropyl PG-Dimonium Chloride Phosphate, Citric Acid, Sodium Hydroxide

Questions?

Call 800-256-4247 or 215-273-8755 (collec t) or visit www.neutrogena.com

Distributed by:
JOHNSON & JOHNSON CONSUMER INC.
Skillman, NJ 08558

PRINCIPAL DISPLAY PANEL - 354 mL Bottle Carton

NEUTROGENA

Scalp Therapy TM

Anti-Dandruff

MEDICATED

DAILY CONTROL

1.8% SALICYLIC ACID

SHAMPOO

Neutrogena®

DERMATOLOGIST RECOMMENDED BRAND

12 FL OZ (354 mL)

Ntg001

NEUTROGENA SCALP THERAPY ANTI-DANDRUFF DAILY CONTROL 
salicylic acid shampoo
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69968-0722
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID18 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
SODIUM C14-16 OLEFIN SULFONATE (UNII: O9W3D3YF5U)  
COCAMIDOPROPYL BETAINE (UNII: 5OCF3O11KX)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR)  
SODIUM LAUROYL SARCOSINATE (UNII: 632GS99618)  
HEXYLENE GLYCOL (UNII: KEH0A3F75J)  
LINOLEAMIDOPROPYL PROPYLENE GLYCOL-DIMONIUM CHLORIDE PHOSPHATE (UNII: 5Q87K461JO)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:69968-0722-1354 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product12/06/2021
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart358H12/06/2021
Labeler - Johnson & Johnson Consumer Inc. (118772437)

Revised: 1/2023
Document Id: ef273f64-2b22-1728-e053-2995a90a85e3
Set id: ca4944cf-7fdb-4720-e053-2995a90a35e9
Version: 2
Effective Time: 20230109
 
Johnson & Johnson Consumer Inc.